Recent Press Releases & News Mentions
2023
September 12, 2024
BMore Collaborator, Dr. Michael Bogenschutz, Awarded NIAAA Grant for Psilocybin in Alcohol Use Disorder Trial
PR Newswire
February 23, 2023
The 22 clinical trials that could make or break the future of the $100 billion psychedelics industry
Business Insider, Dr. Catherine Schuster-Bruce, Yeji Jesse Lee, Shayanne Gal, Annie Fu, and Alex Ford
January 10, 2023
Psilocybin for Alcohol Dependence Trial by B.More Principal Investigator
B.More Press Release
2022
October 14, 2022
B.More Psilocybin for AUD Program Principal Investigator, Dr. Michael Bogenschutz, to Present at Horizons New York Psychedelic Research Forum
B.More Announcement
October 11, 2022
Magic mushrooms: An unlikely possible treatment for the rise in problem drinking
The San Antonio Report, Melissa Fletcher Stoeltje
September 28, 2022
Free Tickets for Psychedelic Capital Presentation by Dr. Michael Bogenschutz and Dr. Judy Ashworth
B.More Announcement
August 25, 2022
B.More Receives FDA Investigational New Drug Approval for Psilocybin Alcohol Use Disorder Program Phase 2b Clinical Trial
B.More Press Release
August 24, 2022
B.More Principal Investigator, Michael Bogenschutz, Publishes Ground-breaking Trial on the Benefits of Psilocybin Therapy for Alcohol Dependence
B.More Press Release
August 24, 2022
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder. A Randomized Clinical Trial
JAMA Psychiatry. Michael P. Bogenschutz, MD1; Stephen Ross, MD1; Snehal Bhatt, MD2; et al
Additional B.More Phase 2A trial peer review published coverage
2022
August 25, 2022
Psilocybin Therapy Sharply Reduces Excessive Drinking, Small Study Shows
New York Times. Andrew Jacobs
August 25, 2022
NYU research finds benefit for patients using ‘magic mushrooms’
ABC7 NY Eyewitness News
August 25, 2022
‘Magic mushroom’ psychedelic may help heavy drinkers quit
Associated Press. Carla K. Johnson
August 24, 2022
Psychedelics with psychotherapy helped heavy drinkers cut back, study finds
AXIOS. Tina Reed
August 24, 2022
Can Magic Mushrooms Help Alcoholics? NYU Study Shows Promise
Bloomberg. Tiffany Karey
August 24, 2022
Psilocybin ‘trips’ combined with therapy reduce alcohol use, study finds
CNN. Sandee LaMotte
August 24, 2022
New Study Shows Psilocybin Reduces Drinking in 83% of Patients
Microdose. Jason Najum
August 24, 2022
Psychedelic drug helped people with alcohol use disorder reduce drinking, study shows
NBC Nightly News. Kaitlin Sullivan, Akshay Syal, M.D., Kori Lynch and Harry Smith
August 24, 2022
Psilocybin alcoholism trial highlights problem for psychedelic science
News Atlas. Rich Haridy
August 24, 2022
Psilocybin shows promise for treating alcohol addiction, new study finds
STAT. Olivia Goldhill
August 24, 2022
Psilocybin-assisted therapy proves effective for alcohol use disorder: study
The Hill. Gianna Melillo
August 24, 2022
Can psilocybin combat mental health issues? How magic mushrooms show promise in fighting addiction.
USA Today. Karen Weintraub
August 24, 2022
Psilocybin, Psychedelic Compound in Magic Mushrooms, Shown Effective for Alcohol Addiction
Wall Street Journal. Daniela Hernandez
Older News and PR Articles
2022
August 11, 2022
Young Psychedelic Philanthropist Blazes Path for the Psychedelic Future
LUCID NEWS. Marc Gunther
July 25, 2022
B.More Submits FDA Investigational New Drug Application for Psilocybin Alcohol Use Disorder Program
BMORE PRESS RELEASE
July 25, 2022
Spotlight Interview | Carey Turnbull, Co-founder and CEO of B.More
Psychedelic Finance
July 25, 2022
Funders at Johns Hopkins Shape The Future of Psychedelic Research
Lucid News, Marc Gunther
March 10, 2022
Grant Supports Development of Training for Psychiatrists in Psychedelic Medicine
Yale Medicine, Christopher Gardner
February 20, 2022
Psychoactive ingredient in ‘magic’ mushrooms may treat depression for much longer than traditional antidepressants when combined with therapy
Business Insider, Dr. Catherine Schuster-Bruce
2021
March 22, 2021
NYU Raises $10M For Psychedelic Research and Training Center
LUCID NEWS. Colin Newton
March 12, 2021
Wealthy donors are fueling a psychedelics renaissance as universities vie for funding to study ‘magic mushrooms’ and MDMA
BUSINESS INSIDER. Yeji Jesse Lee
February 25, 2021
NYU Establishes Center For Psychedelic Medicine With $10 Million From MindMed, Philanthropists
Forbes. Amanda Siebert
2020
February 17, 2020
Business gets ready to trip: How psychedelic drugs may revolutionize mental health care
FORTUNE. Jeffrey M. O’Brien
2019
2018
2015
October 31, 2015
The Trip Treatment: Research into psychedelics, shut down for decades, is now yielding exciting results
The New Yorker. Michael Pollan
January, 2015
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
The Chronicle of Journal of Psychopharmacology 29(3). Michael P Bogenschutz, Alyssa A Forcehimes, Jessica A Pommy, Claire E Wilcox, PCR Barbosa and Rick J Strassman
January, 2015
Can psychedelic compounds play a part in drug dependence therapy?
The British journal of psychiatry. B. Sessa, M. Johnson
2014
September 11, 2014
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
Journal of Psychopharmacology. Matthew W Johnson, Albert Garcia-Romeu, Mary P Cosimano, Roland R Griffiths